Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial

Sponsor
Universiti Putra Malaysia
Study ID
NCT06815250
Status
Recruiting
Apply to this trial

Conditions

  • Influenza
  • Knowledge
  • Tetanus, Diphtheria and Acellular Pertussis Vaccination
  • Vaccination Uptake
  • Vaccine Knowledge
  • Web Based Intervention

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Influenza and Tdap Vaccination Educational and Learning Module — BEHAVIORAL
    Influenza and Tdap learning and educational module delivered via website. The module will cover importance of vaccination for both pregnant women and infant, safety and efficacy of the influenza and TdaP vaccines, timing of vaccination, and addressing common concerns and misconceptions.

Study Details

The goal of this InTroDuce-Programme interventional trial aims to test whether a web-based educational program can improve pregnant women's knowledge about Influenza and Tdap vaccinations and increase their intention to get vaccinated in the future. The main questions it aims to answer are: Does the InTroDuce-Programme increase knowledge and future intention of pregnant mothers to get vaccinated against Influenza and Tdap? How does demographic factors, attitudes and barriers affect vaccination decisions among pregnant mothers? Researchers will compare InTroDuce-Programme to standard care (routine antenatal care) to see if InTroDuce-Programme works to improve knowledge and future intention of pregnant mothers to be vaccinated against Influenza and Tdap. Participants will: Receive the web-based educational module (InTroDuce-Programme), which covers the importance, safety, and effectiveness of vaccinations, as well as addressing common concerns. Be followed up one month after the intervention. Answer questionnaires before and after the intervention to measure changes in vaccination knowledge and future intention to get vaccinated

Key Dates

First listed
Feb 7, 2025
Start date
Jan 13, 2026
Status verified
Apr 2026
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
351 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • No Intervention: Control
    Standard antenatal care
  • Experimental: Intervention
    Influenza and Tdap Vaccination Web-based Educational and Learning Module (InTroDuce-Programme)

Primary Outcome Measure

Knowledge of Influenza and Tdap Vaccination [ Time Frame: 1 month post-intervention ]

Central Contacts

Related Studies